HTA (Health Technology Assessment) Decision Data - 30+ Bodies, Real-Time Updates
收藏资源简介：
HTA ANALYSIS Quickly generate comparative analyses across HTA agencies, products, and companies to understand the reasons the HTA bodies gave a product a certain rating or decision. ECONOMIC MODELS Model details analyzed by the HTA, including economic evaluation type, economic model, time horizon and discount rate; intervention and comparator costs; ICER, incremental costs, and more! BENEFITS ASSESSMENTS Complete clinical analyses conducted by the HTA, decision summaries and details, QALYs and life-years gained for the intervention, and all comparators. - VISUAL INSIGHTS: Suite of visualizations to allow users to quickly understand trends and generate detailed and executive-level insights across agencies, products, therapeutic areas and more. ADDITIONAL DATA TO PROVIDE DEEPER CONTEXTS - Clinical trial data reviewed by the HTA, including all key trial data, results, and published literature on the relevant clinical trials. - 100% of the cost of treatment calculations available for the product and its comparator, allowing for broad comparisons. - Epidemiology data for 700+ indications, including stratified mortality and morbidity rates and projections. API INTEGRATION Pricentric HTA can be integrated into internal systems and analytical tools using our Web API (RESTful). Combined with Pricentric’s core Pricing Database, your organization can access everything it needs from one vendor. SUPPORT On-call experts located across the U.S., Europe, and Asia, offering dedicated support and assistance to meet your most pressing needs.
HTA 分析（HTA ANALYSIS）：可快速生成跨健康技术评估（Health Technology Assessment, HTA）机构、产品及企业的对比分析，以明晰各HTA机构为某一产品给出特定评级或决策的缘由。 经济模型（ECONOMIC MODELS）：分析HTA机构所评估的模型细节，涵盖经济学评价类型、经济模型、时间跨度与贴现率；干预措施与对照措施的成本；增量成本效果比（Incremental Cost-Effectiveness Ratio, ICER）、增量成本等内容！ 效益评估（BENEFITS ASSESSMENTS）：涵盖HTA机构开展的完整临床分析、决策总结与细节、干预措施及所有对照措施的质量调整生命年（Quality-Adjusted Life Year, QALYs）与新增生命年数。 - 可视化洞察（VISUAL INSIGHTS）：提供一套可视化工具套件，可帮助用户快速把握趋势，并生成跨机构、产品、治疗领域等维度的详尽且符合高管决策层级的洞察结果。 用于提供更深入背景的附加数据： - 经HTA机构审查的临床试验数据，涵盖所有关键试验数据、试验结果以及相关临床试验的已发表文献。 - 产品及其对照措施的100%治疗成本计算数据，可支持大范围对比分析。 - 覆盖700余种适应症的流行病学数据，包括分层后的死亡率、发病率及预测数据。 API 集成（API INTEGRATION）：Pricentric HTA可通过其RESTful风格的Web应用程序编程接口（Application Programming Interface, API）集成至内部系统与分析工具中。结合Pricentric核心定价数据库，您的组织可从单一供应商处获取所需的全部资源。 技术支持（SUPPORT）：遍布美国、欧洲与亚洲的待命专家团队，可提供专属支持与协助，以满足您最迫切的业务需求。
